864293-02-7

Basic information

• Product Name: 6,7-DICHLOROQUINAZOLINE-2,4(1H,3H)-DIONE
• Synonyms: 6,7-DICHLOROQUINAZOLINE-2,4(1H,3H)-DIONE
• CAS NO: 864293-02-7
• Molecular Formula: C8H4Cl2N2O2
• Molecular Weight: 231.04
• Mol File: 864293-02-7.mol
• Article Data: 3

Chemical Properties

• Appearance: /
• Density: 1.590±0.06 g/cm3(Predicted)
• PKA: 9.11±0.20(Predicted)
• CAS DataBase Reference: 6,7-DICHLOROQUINAZOLINE-2,4(1H,3H)-DIONE(CAS DataBase Reference)
• NIST Chemistry Reference: 6,7-DICHLOROQUINAZOLINE-2,4(1H,3H)-DIONE(864293-02-7)
• EPA Substance Registry System: 6,7-DICHLOROQUINAZOLINE-2,4(1H,3H)-DIONE(864293-02-7)

Safety Data

• Hazardous Substances Data: 864293-02-7(Hazardous Substances Data)

Upstream product

• 20776-61-8 2-amino-4,5-dichloro-benzoic acid 
• 57-13-6 urea 

Relevant articles and documents

DIACYLGLYCEROL KINASE MODULATING COMPOUNDS

The present disclosure provides diacylglycerol kinase modulating compounds, and pharmaceutical compositions thereof, for treating cancer, including solid tumors, and viral infections, such as HIV or hepatitis B virus infection. The compounds can be used alone or in combination with other agents.

Quinazolines and related heterocyclic compounds and their therapeutic use

A compound of the formula wherein X is CR1 or N; Y is CR3 or N; R1, R3, R4, R5 and R6 are independently H, F, Cl, Br, I, or a hydrocarbon group which optionally contains one or more heteroatoms; R7 is a heterocyclic group including one or more N atoms; R' is Rx or NRyRz wherein Rx, Ry and Rz are each H or the same or different groups, including cyclic groups formed by Ry and Rz with the N atom, of up to 20 C atoms and optionally including up to 3 further heteroatoms selected from N, O and S; or a pharmaceutically acceptable salt, ester or solvate thereof, has therapeutic utility.